Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 3225
MIM: 142971
HGNC: 5130
Ensembl: ENSG00000180806
Variants:
dbSNP: 3225
ClinVar: 3225
TCGA: ENSG00000180806
COSMIC: HOXC9
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000180806 | ENST00000303450 | P31274 |
| ENSG00000180806 | ENST00000303450 | A0A024RAZ6 |
| ENSG00000180806 | ENST00000508190 | P31274 |
| ENSG00000180806 | ENST00000508190 | A0A024RAZ6 |
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38446596 | 2024 | HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma. | 1 |
| 38446596 | 2024 | HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma. | 1 |
| 36272177 | 2022 | circRNA-mediated upregulation of HOXC9 is correlated with poor outcome and immune microenvironment infiltrates in LUAD. | 3 |
| 36272177 | 2022 | circRNA-mediated upregulation of HOXC9 is correlated with poor outcome and immune microenvironment infiltrates in LUAD. | 3 |
| 34159686 | 2021 | Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis. | 5 |
| 34159686 | 2021 | Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis. | 5 |
| 32816159 | 2020 | HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients. | 10 |
| 32816159 | 2020 | HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients. | 10 |
| 31414766 | 2019 | Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer. | 5 |
| 31414766 | 2019 | Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer. | 5 |
| 30205370 | 2018 | miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer. | 13 |
| 30205370 | 2018 | miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer. | 13 |
| 26582930 | 2016 | Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1. | 16 |
| 26647900 | 2016 | Fat depot-specific expression of HOXC9 and HOXC10 may contribute to adverse fat distribution and related metabolic traits. | 21 |
| 26582930 | 2016 | Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1. | 16 |
Citation
Dessen P
HOXC9 (homeobox C9)
Atlas Genet Cytogenet Oncol Haematol. 2015-05-01
Online version: http://atlasgeneticsoncology.org/gene/55191/hoxc9-(homeobox-c9)
